Clopidogrel probably induced hepatic toxicity

被引:6
作者
Quintana, JAD [1 ]
Sáenz, MJ [1 ]
Montero, AR [1 ]
Gutiérrez, JMH [1 ]
机构
[1] Hosp Univ Virgen Macarena, Serv Farmacol Clin & Aparto Digest, Seville, Spain
来源
MEDICINA CLINICA | 2002年 / 119卷 / 01期
关键词
D O I
10.1016/S0025-7753(02)73305-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:37 / 37
页数:1
相关论文
共 7 条
[1]  
Barer D, 1997, LANCET, V349, P355, DOI 10.1016/S0140-6736(05)62852-8
[2]   Thrombotic thrombocytopenic purpura associated with clopidogrel. [J].
Bennett, CL ;
Connors, JM ;
Carwile, JM ;
Moake, JL ;
Bell, WR ;
Tarantolo, SR ;
McCarthy, LJ ;
Sarode, R ;
Hatfield, AJ ;
Feldman, MD ;
Davidson, CJ ;
Tsai, HM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (24) :1773-1777
[3]  
Cheung RTF, 2000, NEW ENGL J MED, V343, P1192
[4]   Clopidogrel and thrombotic thrombocytopenic purpura [J].
Hankey, GJ .
LANCET, 2000, 356 (9226) :269-270
[5]   Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis [J].
Maria, VAJ ;
Victorino, RMM .
HEPATOLOGY, 1997, 26 (03) :664-669
[6]   A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].
NARANJO, CA ;
BUSTO, U ;
SELLERS, EM ;
SANDOR, P ;
RUIZ, I ;
ROBERTS, EA ;
JANECEK, E ;
DOMECQ, C ;
GREENBLATT, DJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245
[7]  
Willens H J, 2000, Am J Ther, V7, P317, DOI 10.1097/00045391-200007050-00009